Bladder cancer and arsenic

Matthew K. Medeiros, A Jay Gandolfi

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Epidemiological studies have established an association between arsenic exposure and the development of bladder cancer. Studies in arsenic-endemic areas such Taiwan, Chile, and Argentina have led the International Agency for Research on Cancer (IARC) to list arsenic as an environmental contaminant and human carcinogen. Genetic polymorphisms in arsenic biotransformation enzymes provide individuals with varying degrees of susceptibility to arsenic exposure or development of cancer. To determine the biological effects of and mechanisms involved with arsenic exposure in humans, in vivo and in vitro models have been developed. With in vitro models such as the human urothelial cells (HUC) line, UROtsa, researchers have found that arsenical toxicity can vary with oxidation state and methylation, arsenic impacts the intracellular signaling of bladder cells by promoting proliferation and growth, arsenic can change the redox state of the cells, and arsenical interactions lead to alterations in normal gene expression patterns with concomitant epigenetic changes.

Original languageEnglish (US)
Title of host publicationArsenic
Subtitle of host publicationExposure Sources, Health Risks, and Mechanisms of Toxicity
Publisherwiley
Pages163-191
Number of pages29
ISBN (Electronic)9781118876992
ISBN (Print)9781118511145
DOIs
StatePublished - Oct 30 2015

Keywords

  • Animal models
  • Arsenic biotransformation process
  • Arsenic exposure
  • Bladder cancer
  • Gene expression patterns
  • In vitro models
  • Intracellular signaling

ASJC Scopus subject areas

  • Chemistry(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Engineering(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'Bladder cancer and arsenic'. Together they form a unique fingerprint.

Cite this